checkAd

    Terravia - 500 Beiträge pro Seite

    eröffnet am 22.07.16 10:48:27 von
    neuester Beitrag 13.09.18 10:10:01 von
    Beiträge: 8
    ID: 1.235.548
    Aufrufe heute: 0
    Gesamt: 729
    Aktive User: 0

    ISIN: US88105A1060 · WKN: A2AJUS
    0,0028
     
    USD
    -6,67 %
    -0,0002 USD
    Letzter Kurs 31.01.18 Nasdaq OTC

    Werte aus der Branche Finanzdienstleistungen

    WertpapierKursPerf. %
    3,0000+500,00
    0,6800+312,12
    29,77+37,04
    1,6800+15,87
    12,300+14,37
    WertpapierKursPerf. %
    0,7900-12,22
    1,5000-23,08
    0,7500-25,00
    17,850-30,00
    1,5000-90,00

     Durchsuchen

    Begriffe und/oder Benutzer

     

    Top-Postings

     Ja Nein
      Avatar
      schrieb am 22.07.16 10:48:27
      Beitrag Nr. 1 ()
      ...ist der neue Name von Solazyme;

      Thread: Solazyme - Biofuel IPO
      4 Antworten
      Avatar
      schrieb am 09.05.17 14:35:40
      Beitrag Nr. 2 ()
      Antwort auf Beitrag Nr.: 52.889.962 von R-BgO am 22.07.16 10:48:27
      seitdem nochmal "so eben" gezehntelt,
      aus Sicht der Altaktionäre ist der Totalverlust damit wohl ein "fait accompli";

      trotzdem finde ich nicht uninteressant, was sie machen:


      Success of AlgaPrime™ DHA in Aquaculture Market Drives Increased Commercial Distribution

      Expansion of Agreement with BioMar Signals Further Industry Adoption


      Mar 8th, 2017

      SAN FRANCISCO, CA & WHITE PLAINS, N.Y.--(BUSINESS WIRE)-- TerraVia (NASDAQ: TVIA), Bunge Limited (NYSE:BG) ("Bunge") and BioMar Group ("BioMar") today announced the expansion of their distribution agreement for AlgaPrime™ DHA - a native, whole algae specialty feed ingredient high in omega-3 DHA - making the product commercially available at scale to salmon farmers and other participants in the aquaculture industry.

      Building on successful joint aquaculture feed trials in 2016, over the past six months BioMar has significantly increased deliveries of commercial feed containing AlgaPrime™ DHA to leading salmon farmers.

      Developed to reduce dependency on marine fisheries and enhance the nutritional value of seafood, AlgaPrime™ DHA is expected to be a key feed ingredient in the future of aquaculture.

      "We believe AlgaPrime™ DHA will be a significant contributor to the further development of salmon products with a desirable nutritional profile. We take pride in driving the sustainability agenda of the industry and are pleased to be the first feed producer to bring this new feed ingredient to our customers while ensuring economies of scale," said Jan Sverre Røsstad, Vice President and Head of Salmon Division at BioMar Group.

      Graham Ellis, Senior Vice President, Business Development, TerraVia said, "AlgaPrime™ DHA offers a traceable and sustainable source of omega-3s. As an alternative to ingredients like fish oil and fishmeal that come from small oily fish, AlgaPrime™ DHA can help customers meet consumer and retailer demand for salmon with enhanced levels of omega-3s."

      "Produced at the TerraVia and Bunge joint venture production facility in Brazil using renewable energy and a native algae strain, AlgaPrime™ DHA allows for responsible industry growth. We're producing it at a scale relevant to the market right now, and our expanded agreement with BioMar will help deliver on the potential of this business," said Miguel Oliveira, Vice President, Global Innovation, Bunge Limited.
      3 Antworten
      Avatar
      schrieb am 09.05.17 14:36:37
      Beitrag Nr. 3 ()
      Antwort auf Beitrag Nr.: 54.900.353 von R-BgO am 09.05.17 14:35:40
      Biomar
      gehört zur Schouw Gruppe

      Thread: Schouw & Co
      Avatar
      schrieb am 07.12.17 14:04:00
      Beitrag Nr. 4 ()
      Antwort auf Beitrag Nr.: 54.900.353 von R-BgO am 09.05.17 14:35:40TerraVia Holdings, Inc. Enters Into Agreement for the Sale of Substantially All of Its Assets Subject to Competitive Bidding Process

      TerraVia Files Voluntary Chapter 11 Petitions to Facilitate Sale Process with a Commitment for DIP Financing to Support Ongoing Operations



      SAN FRANCISCO--(BUSINESS WIRE)--

      TerraVia Holdings, Inc. (NASDAQ:TVIA) ("TerraVia"), a next-generation food, nutrition and specialty ingredients company and pioneer in algae innovation, announced today that it has entered into a "stalking horse" stock and asset purchase agreement with Corbion N.V., a Netherlands-based global leader in food ingredients and biobased technologies, to acquire substantially all of TerraVia's assets in a sale process under Section 363 of the Bankruptcy Code.

      The purchase agreement provides TerraVia with a binding bid of $20 million in cash along with the assumption of certain liabilities, which is subject to higher or otherwise better offers. As part of the transaction, Corbion will be assuming the ongoing financial obligations of the business and its joint venture ownership, therefore the total financial commitment is expected to be in excess of the cash purchase price. Through this proposed transaction, TerraVia employees, who bring with them a wide range of highly valued skills and expertise, together with its customers, have an opportunity to benefit from joining a global leader in its markets.

      To facilitate its competitive transaction process, TerraVia and its wholly owned U.S. subsidiaries have filed voluntary petitions for reorganization under chapter 11 of the Bankruptcy Code in the United States Bankruptcy Court for the District of Delaware (the "Bankruptcy Court") under the Case number 17-11655. Additional information can be found at http://www.kccllc.net/TerraVia.

      In addition, TerraVia also announced that it has received a commitment for debtor-in-possession (DIP) financing from holders of approximately 63% of the outstanding principal amount of its senior unsecured convertible notes. The DIP financing will be used to finance the working capital needs of TerraVia's business through the completion of the sale transaction and to support payments to vendors for post-petition purchases in the ordinary course.

      The DIP financing announced today provides the necessary financing to support continued operations and TerraVia's ability to service customer demand, while the Section 363 bankruptcy restructuring process provides the tools to execute an expedited and orderly strategic transaction. This process will create a level playing field for all interested bidders to compete to provide the highest or otherwise best offer for certain or all of TerraVia's assets.

      Pursuant to section 363 of the Bankruptcy Code, TerraVia intends to implement bidding procedures to allow other qualified bidders the opportunity to submit bids through a court-supervised process to purchase certain or all of the assets being sold. TerraVia anticipates that a sale will be completed within 60 to 90 days. Rothschild Inc. is acting as TerraVia's financial advisor and investment banker to lead the sales process under the bid procedures and Davis Polk & Wardwell LLP is acting as restructuring and corporate counsel to TerraVia. Interested bidders are encouraged to contact, as soon as practicable: Nicholas Barnes / Tero Jänne at Rothschild Inc., 1251 Avenue of the Americas, 33rd Floor, New York, NY 10020, tel. +1 212 403 3500.

      The chapter 11 cases and the sale process should have no material impact on TerraVia's ability to fulfill its obligations to its customers and employees going forward. TerraVia has filed a series of motions with the Bankruptcy Court requesting authority to continue normal operations, including requesting Bankruptcy Court authority to continue paying employee wages and salaries, certain vendors and customer obligations in the ordinary course without interruption. TerraVia will continue its efforts to work closely with its suppliers and partners to meet ongoing obligations and continue its business without interruption.
      1 Antwort
      Avatar
      schrieb am 07.12.17 14:11:12
      Beitrag Nr. 5 ()
      Antwort auf Beitrag Nr.: 56.390.143 von R-BgO am 07.12.17 14:04:00
      Käufer ist sogar notiert...
      Thread: Corbion - hat Terravia Assets gekauft


      Terravia ist meine 63. Insolvenz;


      over-and-out

      Trading Spotlight

      Anzeige
      InnoCan Pharma
      0,1900EUR +2,98 %
      Aktie kollabiert! Hier der potentielle Nutznießer! mehr zur Aktie »
      Avatar
      schrieb am 22.08.18 14:38:30
      Beitrag Nr. 6 ()
      clustering the dead
      Avatar
      schrieb am 12.09.18 12:18:52
      Beitrag Nr. 7 ()
      Friedhof der Insolvenzen
      1 Antwort
      Avatar
      schrieb am 13.09.18 10:10:01
      Beitrag Nr. 8 ()
      Antwort auf Beitrag Nr.: 58.679.718 von R-BgO am 12.09.18 12:18:52Zumindest leben die Überreste bei Corbion weiter....auch wenn mich die Performance von dem Laden auch nicht unbedingt aus den Latschen haut.


      Beitrag zu dieser Diskussion schreiben


      Zu dieser Diskussion können keine Beiträge mehr verfasst werden, da der letzte Beitrag vor mehr als zwei Jahren verfasst wurde und die Diskussion daraufhin archiviert wurde.
      Bitte wenden Sie sich an feedback@wallstreet-online.de und erfragen Sie die Reaktivierung der Diskussion oder starten Sie
      hier
      eine neue Diskussion.

      Investoren beobachten auch:

      WertpapierPerf. %
      -1,99
      +0,07
      0,00
      +0,38
      0,00
      -1,11

      Meistdiskutiert

      WertpapierBeiträge
      213
      196
      195
      71
      33
      32
      28
      26
      25
      24
      Terravia